TrialDiabetes, obesity & metabolism2018

N-terminal pro-brain natriuretic peptide (NT-proBNP) predicts the cardio-renal response to aliskiren in patients with type 2 diabetes at high renal and cardiovascular risk.

Nienke M A Idzerda et al.PubMed ↗Full text ↗Publisher ↗

No numbers read from the abstract.